StavrosStavrakisMD
Cardiology • Oklahoma City, OKCardiac Electrophysiology
Associate Professor, Medicine, University of Oklahoma College of Medicine
Dr. Stavrakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 NE 10th St
Oklahoma City, OK 73104Phone+1 405-271-7001Fax+1 405-271-3064
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012- University of Oklahoma Health Sciences CenterFellowship, Cardiovascular Disease, 2008 - 2011
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2005 - 2008
University of AthensClass of 2003
Certifications & Licensure
OK State Medical License 2007 - 2025- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Clinical Trials
- Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion Start of enrollment: 2012 Mar 01
- Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients Start of enrollment: 2013 Sep 01
- Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction Start of enrollment: 2017 Dec 12
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsContribution of circulating Mfge8 to human T2DM and cardiovascular disease.Madhusmita Rout, Megan W Malone-Perez, Gilseung Park, Megan Lerner, J Kimble Frazer
Gene. 2024-11-15 - Sex differences in atrial fibrillation ablation outcomes in patients with heart failure.Siddharth Agarwal, Kassem Farhat, Muhammad Salman Khan, Christopher V DeSimone, Abhishek Deshmukh
Journal of Interventional Cardiac Electrophysiology. 2024-11-01 - 1 citationsThe impact of atrial fibrillation on clinical outcomes in heart failure with mid-range and preserved ejection fraction patients.Irina Mustafina, Khaled Elkholey, Marat Fudim, Stavros Stavrakis
Heart Rhythm. 2024-11-01
Journal Articles
- The Efficacy of Coronary Sinus Reducer in Patients with Refractory Angina—A Systematic Review of the LiteratureStavros Stavrakis, MD, Journal of Interventional Cardiology
Authored Content
- A Potential Relationship Between Gut Microbes and Atrial Fibrillation: Trimethylamine N-oxide, a Gut Microbe-Derived Metabolite, Facilitates the Progression of Atrial FibrillationFebruary 2018
Press Mentions
A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart FailureApril 21st, 2022- OU Health Doctor Explains Risk of Myocarditis with COVID-19 Vaccine Versus COVID-19 VirusSeptember 1st, 2021
- Smartphone ECG Screening App Aided Detection of AF Among American IndiansApril 24th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
